IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Bioverativ Therapeutics, Inc./swedish Orphan Biovitrum Ab (publ) opposition analysis
COMPANY ANALYSIS
Latest oppositions filed by Bioverativ Therapeutics, Inc./swedish Orphan Biovitrum Ab (publ)
Patent Number:
EP2256135
Title:
Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor
Applicant:
CSL BEHRING GMBH
Opposition Date:
Dec 13, 2019
Latest oppositions filed by Bioverativ Therapeutics, Inc./swedish Orphan Biovitrum Ab (publ)
Patent Number
Title
Applicant
Opposition Date
EP2256135
Proteolytically Cleavable Fusion Protein Comprising A Blood Coagulation Factor
CSL BEHRING GMBH
Dec 13, 2019
Competitors of Bioverativ Therapeutics, Inc./swedish Orphan Biovitrum Ab (publ)
CSL BEHRING GMBH
Want to track Bioverativ Therapeutics, Inc./swedish Orphan Biovitrum Ab (publ)?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch